{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:55:38Z","timestamp":1648558538311},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.484","type":"journal-article","created":{"date-parts":[[2005,6,6]],"date-time":"2005-06-06T06:04:49Z","timestamp":1118037889000},"page":"484-489","source":"Crossref","is-referenced-by-count":4,"title":["High-dose Melphalan Followed by Autologous Stem Cell Support in Primary Systemic AL Amyloidosis with Multiple Organ Involvement"],"prefix":"10.2169","volume":"44","author":[{"given":"Yasuhiro","family":"SHIMOJIMA","sequence":"first","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"MATSUDA","sequence":"additional","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"ISHII","sequence":"additional","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"KOYAMA","sequence":"additional","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanji","family":"YAMAMOTO","sequence":"additional","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetaka","family":"SHIMODAIRA","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"SAKASHITA","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"KOIKE","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Shinshu University School of Medicine, Matsumoto"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ichi","family":"IKEDA","sequence":"additional","affiliation":[{"name":"Third Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol <b>32<\/b>: 45-59, 1995."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood <b>99<\/b>: 4276-4282, 2002.","DOI":"10.1182\/blood.V99.12.4276"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med <b>91<\/b>: 141-157, 1998.","DOI":"10.1093\/qjmed\/91.2.141"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Iggo N, Littlewood T, Winearls CG. Prospects for effective treatment of AL amyloidosis? Q J Med <b>93<\/b>: 257-260, 2000.","DOI":"10.1093\/qjmed\/93.5.257"},{"key":"5","unstructured":"5) Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood <b>91<\/b>: 3662-3670, 1998."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Dispenzieri A, Kyle RA, Lacy MQ, et al. Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study. Blood <b>103<\/b>: 3960-3963, 2004.","DOI":"10.1182\/blood-2003-12-4192"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Gertz MA, Lacy MQ, Dispenzieri A, et al. Stem cell transplantation for management of primary systemic amyloidosis. Am J Med <b>113<\/b>: 549-555, 2002.","DOI":"10.1016\/S0002-9343(02)01208-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Dispenzieri A, Lacy MQ, Kyle RA, et al. Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol <b>19<\/b>: 3350-3356, 2001.","DOI":"10.1200\/JCO.2001.19.14.3350"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Blum W, Khoury H, Lin HS, et al. Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study. Biol Blood Marrow Transplant <b>9<\/b>: 397-404, 2003.","DOI":"10.1016\/S1083-8791(03)00106-X"},{"key":"10","unstructured":"10) Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem <b>48<\/b>: 1437-1444, 2002."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Witzenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J <b>103<\/b>: 468-473, 1982.","DOI":"10.1016\/0002-8703(82)90331-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Moreau P, Leblond V, Bourquelot P, et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. Br J Haematol <b>101<\/b>: 766-769, 1998.","DOI":"10.1046\/j.1365-2141.1998.00772.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mollee PN, Wechalekar AD, Pereira DL, et al. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplant <b>33<\/b>: 271-277, 2004.","DOI":"10.1038\/sj.bmt.1704344"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gertz MA, Lacy MQ, Gastineau DA, et al. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL). Bone Marrow Transplant <b>26<\/b>: 963-969, 2000.","DOI":"10.1038\/sj.bmt.1702643"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gono T, Matsuda M, Shimojima Y, et al. VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese criteria for patient selection and our experiences. Amyloid: J Protein Folding Disord <b>11<\/b>: 245-256, 2004.","DOI":"10.1080\/13506120412331336907"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol <b>16<\/b>: 1135-1141, 1990.","DOI":"10.1016\/0735-1097(90)90545-Z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation <b>107<\/b>: 2446-2452, 2003.","DOI":"10.1161\/01.CIR.0000068313.67758.4F"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Takemura G, Takatsu Y, Doyama K, et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol <b>31<\/b>: 754-765, 1998.","DOI":"10.1016\/S0735-1097(98)00045-X"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Palladini G, Campana C, Klersy C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation <b>107<\/b>: 2440-2445, 2003.","DOI":"10.1161\/01.CIR.0000068314.02595.B2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Saba N, Sutton D, Ross H, et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant <b>24<\/b>: 853-855, 1999.","DOI":"10.1038\/sj.bmt.1702005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Stevens JM, Patton WN, Heaton DC, et al. Autologous PBSCT in patients with cardiac amyloidosis. Bone Marrow Transplant <b>26<\/b>: 588-589, 2000.","DOI":"10.1038\/sj.bmt.1702551"},{"key":"22","unstructured":"22) Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem <b>48<\/b>: 1437-1444, 2002."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Abraham RS, Katzmann JA, Clark RJ, Bradwell AR, Kyle RA, Gertz MA. Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol <b>119<\/b>: 274-278, 2003.","DOI":"10.1309\/LYWM47K2L8XYFFB3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lachmann HJ, Gallimore R, Gillmore JD, et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol <b>122<\/b>: 78-84, 2003.","DOI":"10.1046\/j.1365-2141.2003.04433.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/5\/44_5_484\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T19:56:25Z","timestamp":1497642985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/5\/44_5_484\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.484","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}